As one of cell and gene therapy's premier clinical scientists, Dr. Malcolm Brenner's
renowned work and passion has taken him from the collegiate grounds of Cambridge,
England to the humid bayous of Houston, Texas. Born and raised in London, Dr. Brenner
received both his medical degree and his PhD at the distinguished University of Cambridge.
In 1990 he crossed the Atlantic to work at St. Jude Children's Research Hospital in
Memphis, Tennessee as the director of the Cell and Gene Therapy Program where he conducted
the first human gene therapy studies on bone marrow stem cells – a truly pioneering
achievement. Since that time, Dr. Brenner has held a number of positions including
President of ISCT from 1999 to 2000 and President of the American Society of Gene
Therapy from 2002 to 2003. From Memphis, Dr. Brenner moved 600 miles south west, finding
his current home as a full-time faculty member at the Center for Cell and Gene Therapy
at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital.
Over the years, Dr. Brenner has been recognized as a pioneer in cell and gene therapy
with a number of accolades that include the American Society for Gene and Cell Therapy
Outstanding Achievement Award, Human Gene Therapy's Pioneer Award, the American Society
of Hematology Mentor Award, the European Society of Gene and Cell Therapy Outstanding
Achievement Award, and most notably being elected as a member of the American Association
of Physicians and of the National Academy of Medicine.
To read this article in full you will need to make a payment
© 2019 Published by Elsevier B.V. on behalf of International Society for Cell and Gene Therapy.